Filtros : "Holanda" "European Journal of Pharmaceutical Sciences" "Indexado na Base de Dados Current Contents" Limpar

Filtros



Refine with date range


  • Source: European Journal of Pharmaceutical Sciences. Unidades: FCF, ICB

    Subjects: PELE, MELANOMA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARVALHO, Vanessa F. M et al. Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models. European Journal of Pharmaceutical Sciences, v. 109, p. 131-143, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.07.023. Acesso em: 20 out. 2024.
    • APA

      Carvalho, V. F. M., Migotto, A., Giacone, D. V., Lemos, D. P. de, Zanoni, T. B., Maria-Engler, S. S., et al. (2017). Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models. European Journal of Pharmaceutical Sciences, 109, 131-143. doi:10.1016/j.ejps.2017.07.023
    • NLM

      Carvalho VFM, Migotto A, Giacone DV, Lemos DP de, Zanoni TB, Maria-Engler SS, Costa-Lotufo LV, Lopes LB. Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109 131-143.[citado 2024 out. 20 ] Available from: https://doi.org/10.1016/j.ejps.2017.07.023
    • Vancouver

      Carvalho VFM, Migotto A, Giacone DV, Lemos DP de, Zanoni TB, Maria-Engler SS, Costa-Lotufo LV, Lopes LB. Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109 131-143.[citado 2024 out. 20 ] Available from: https://doi.org/10.1016/j.ejps.2017.07.023
  • Source: European Journal of Pharmaceutical Sciences. Unidades: ICB, FCF

    Subjects: HIPERCOLESTEROLEMIA, EXPRESSÃO GÊNICA, RNA MENSAGEIRO, FISIOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RODRIGUES, Alice Cristina et al. Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells. European Journal of Pharmaceutical Sciences, v. 93, p. 431-436, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2016.08.044. Acesso em: 20 out. 2024.
    • APA

      Rodrigues, A. C., Neri, E. A., Veríssimo Filho, S., Rebouças, N. A., Hirata, R. D. C., & Yu, A. M. (2016). Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells. European Journal of Pharmaceutical Sciences, 93, 431-436. doi:10.1016/j.ejps.2016.08.044
    • NLM

      Rodrigues AC, Neri EA, Veríssimo Filho S, Rebouças NA, Hirata RDC, Yu AM. Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2016 ; 93 431-436.[citado 2024 out. 20 ] Available from: https://doi.org/10.1016/j.ejps.2016.08.044
    • Vancouver

      Rodrigues AC, Neri EA, Veríssimo Filho S, Rebouças NA, Hirata RDC, Yu AM. Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2016 ; 93 431-436.[citado 2024 out. 20 ] Available from: https://doi.org/10.1016/j.ejps.2016.08.044

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024